People who caught mild Covid had increased risk of blood clots, British study finds

People who caught mild Covid had increased risk of blood clots, British study finds


A patient receives a coronavirus disease (COVID-19) test at Sparrow Laboratories Drive-Thru Services in Lansing, Michigan, December 27, 2021.

Emily Elconin | Reuters

People who caught mild cases of Covid-19 during the first year of the pandemic had a higher risk of developing blood clots than those who were not infected, according to a large study published by British scientists this week.

Patients with mild Covid, defined as those not hospitalized, were 2.7 times more likely to develop blood clots, according to the study published in the British Medical Journal’s Heart on Monday. They were also 10 times more likely to die than people who did not have Covid.

Scientists affiliated with Queen Mary University of London followed 18,000 people who caught Covid during the first year of the pandemic and compared their health outcomes with nearly 34,000 people who didn’t.

Participants were tracked until they developed cardiovascular disease, died or until the study ended in March 2021. Most of the study was conducted before the vaccines rolled out in the U.K. in December 2020.

While people with mild Covid had an increased risk of blood clots, patients hospitalized with the virus had a significantly higher risk of cardiovascular disease in general. The risk of cardiovascular disease for mild and severe cases was highest in the first 30 days after infection but continued later.

Patients hospitalized with Covid were 28 times more likely to develop blood clots, 22 times more likely to suffer heart failure, and17 times more likely to have a stroke, according to the study. Overall, they were more than 100 times more likely to die than people who didn’t have Covid.

The scientists said their findings highlight the importance of monitoring even people who had mild Covid for cardiovascular disease over the the long term.

“Our findings highlight the increased cardiovascular risk of individuals with past infection, which are likely to be greater in countries with limited access to vaccination and thus greater population exposure to COVID-19,” the authors of the study wrote.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill
Health

Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill

Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A closely watched pill from […]

Read More
Why U.S. cattle ranchers say Trump’s Argentine beef import talk is no solution to domestic food supply threat
Health

Why U.S. cattle ranchers say Trump’s Argentine beef import talk is no solution to domestic food supply threat

Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images Cattle ranchers in Texas and around the country […]

Read More
Anthropic launches Claude Life Sciences to give researchers an AI efficiency boost
Health

Anthropic launches Claude Life Sciences to give researchers an AI efficiency boost

Dario Amodei, Anthropic CEO, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 21st, 2025. Gerry Miller | CNBC Anthropic on Monday announced Claude for Life Sciences, a new offering for researchers to use the company’s artificial intelligence technology in the advancement of scientific discovery.  Claude for Life Sciences is […]

Read More